Amsal Pharmaceuticals Company

What Amsal Pharmaceuticals Company does

Amsal Pharmaceuticals d.o.o. Sarajevo is a privately held pharmaceutical manufacturer founded in 2013 and headquartered in Vogošća, a suburb of Sarajevo, Bosnia and Herzegovina. The company produces and distributes generic prescription (Rx) medicines, over-the-counter (OTC) medications, dietary supplements, cosmetics with special purpose, and medical devices across a portfolio of roughly 40+ SKUs organized under sub-brands including OsteoRevital® (joint health), DenaVin 3® (vitamin D), Ferrosal® (iron), Isomar®, and Prosturo® NEO (prostate health). Therapeutic coverage spans cardiovascular, central nervous system, respiratory, urological, anti-infective, and metabolic conditions at the Rx level, with adjacent consumer health products in the supplement and OTC categories.

The business operates GMP-certified manufacturing under a quality system aligned with GMP/EU guidelines, with documented compliance culture emphasized across company materials. Its go-to-market is direct domestic distribution within Bosnia and Herzegovina, supplemented by content marketing through a Bosnian-language website and dedicated micro-sites for sub-brands. Amsal additionally pursues three adjacent revenue strategies: contract manufacturing for partners, in-licensing of new molecules to broaden the portfolio, and regulatory representation services for foreign companies seeking to register products in the BiH market. The company has publicly stated its intention to recruit international distributors for export of its own products.

Amsal reports a headcount of 101–250 employees, no external funding rounds, no parent company, no disclosed revenue, and no named enterprise customers. There is no evidence of AI, machine learning, or proprietary technology platform capabilities in the source data. The customer base is composed of general healthcare consumers purchasing through domestic pharmacy and retail channels, with no concentration in named institutional accounts. The company's stated differentiators are its flexible private-company posture, GMP/EU-aligned quality systems, multi-category portfolio breadth, and willingness to enter non-stereotypical partnerships.

Name

Amsal Pharmaceuticals Company

Legal name

Amsal Pharmaceuticals d.o.o. Sarajevo

Website

https://amsal.ba

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

Amsal Pharmaceuticals d.o.o. Sarajevo is a privately held Bosnian pharmaceutical manufacturer producing generic prescription and OTC medicines, dietary supplements, cosmetics, and medical devices for domestic healthcare consumers, with additional contract manufacturing and regulatory representation services.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

Keywords

• Generic pharmaceuticals
• OTC medications
• Dietary supplements
• Contract manufacturing
• Medical devices

Headquarters

HQ city

Vogosca

HQ country

Bosnia & Herzegovina

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels2 records

Core offering

Amsal Pharmaceuticals is a private pharmaceutical company that manufactures and distributes generic prescription (Rx) medicines, OTC medications, dietary supplements, cosmetics with special purpose, and medical devices from its headquarters in Vogošća, Sarajevo. Its portfolio spans therapeutic areas including cardiovascular, urology, neurology, psychiatry, pain management, respiratory, and men's health, alongside nutritional supplements for joint health, urinary tract health, iron deficiency, vitamin D, and prostate health. The company also offers contract manufacturing, regulatory representation, and in-licensing services to other pharmaceutical firms seeking entry into the Bosnian market.

Product overview

Amsal Pharmaceuticals Company is a private pharmaceutical company focused on manufacturing and distribution of high-quality, effective and safe generic prescription (Rx) and OTC medications as well as dietary supplements and medical devices. The product portfolio spans five categories: Prescription medications (Addamo, Rosstat, Nebicor, Klavamox, Escita, Spyro, Tamsal, Eprosta, and others); Dietary supplements (DenaVin 3 for vitamin D, Ferrosal iron supplements, OsteoRevital joint health products, Prosturo/Prosturo NEO prostate support, Cysturo urinary tract products, N-Oxyal, Trawelin, Lit Control); OTC medications (Paracetamol Amsal, ParaCet Flu); Cosmetics with special purpose (Aftalip oral gel); and Medical devices (Auridol ear drops, Atix tick removal set). The company emphasizes GMP standards, quality management systems, and continuous development aligned with market needs.

Differentiator

Problem solved

Functional benefit

Brands

• OsteoRevital®: Joint health dietary supplement brand
• DenaVin 3®
• Ferrosal®
• Isomar®
• Prosturo® NEO

Products and services

• Generic Prescription Medications (Rx) Generic prescription medicines supplied to pharmacies in tablet, capsule, oral suspension, inhalation powder, and film-coated forms for conditions including hypertension, hyperphosphatemia, asthma, BPH, depression, Alzheimer's, schizophrenia, erectile dysfunction, and bacterial infections.
• OTC Medications (Paracetamol Amsal line, ParaCet Flu) Over-the-counter analgesic and cold/flu products for self-medication by general consumers, supplied to pharmacies in tablet, oral solution, and powder-for-solution formats.
• OsteoRevital® Joint Health Supplements Joint health dietary supplements containing glucosamine, collagen, and plant extracts for joint function maintenance, targeted at adults with joint health concerns, including PRO line in forest fruit flavor.
• Ferrosal® Iron Supplements Iron dietary supplement line for increased iron needs, available in capsule and oral suspension forms, including a pediatric formulation for newborns, infants, and children with iron deficiency.
• Prosturo® Prostate Health Supplements Prostate health dietary supplements for men, supplying zinc, vitamin B6, vitamin E, and plant extracts (pumpkin seed, saw palmetto, nettle, African plum bark) to support prostate and urogenital tract health.
• Cysturo® Urinary Tract Supplements Dietary supplements for urinary system health, including pediatric and adult formulations combining cranberry extract, horsetail, vitamin C, and zinc to support normal urinary tract function and immunity.
• DenaVin 3® Vitamin D3 Supplements Vitamin D3 dietary supplements in capsule and sublingual spray formats for bone health, immune function support, and reduction of fall risk in older adults.
• Other Dietary Supplements (N-Oxyal, Lit Control pH Balance, Trawelin, Isomar) Miscellaneous dietary supplements: N-Oxyal for nervous system and oxidative stress support; Lit Control pH Balance to inhibit kidney stone crystallization; Trawelin for motion sickness relief during travel; and Isomar product line.
• Aftalip® Oral Care Gel (Cosmetic with Special Purpose) Active dermo-cosmetic oral gel for care and protection of oral mucosa, recommended for painful abrasions, denture and orthodontic appliance irritations, aphthae, and oral thrush.
• Medical Devices (Auridol ear drops, Atix tick removal set) Medical device products for consumer use: Auridol ear drops for ear care and Atix tick removal set featuring a cryogenic spray and tweezers for safe tick removal.
• International Distribution Partnerships (Out-licensing) B2B service offering Amsal products through international distributors who handle local registration and distribution in their respective markets.
• In-licensing and Regulatory Representation Services for Foreign Pharma Companies B2B service for foreign pharmaceutical companies: end-to-end regulatory representation and product registration in BiH, plus in-licensing opportunities to bring new products into Amsal's portfolio.

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Distributors for International MarketscoreChannel Partner/ Reseller/ DistributorAmsal is seeking distributors who would perform registration and distribution services for Amsal products in other markets.
• Licensing Partners (In-licensing)coreOEM/ Whitelabel/ Licensing PartnerOne of Amsal's core goals is to further develop their product portfolio, constantly seeking opportunities to introduce new products through license agreements.
• Foreign Companies (Representation in BiH)coreStrategic or Co-development PartnerAmsal offers complete representation services for foreign companies, including handling and performing the complete product registration process in the BiH market.

Recent moves6 records

Expansion highlights4 records

Direct peers

• Bosnalijek: Bosnia and Herzegovina's largest domestic pharmaceutical manufacturer, producing generic Rx and OTC medicines plus dietary supplements for the BiH market and export — the closest head-to-head competitor to Amsal within Bosnia.
• Alkaloid: North Macedonian pharmaceutical company manufacturing generic Rx, OTC, and consumer health products for Southeastern Europe — closely comparable to Amsal in scale, product breadth, and regional footprint.
• Hemofarm: Serbian-based generic pharmaceutical manufacturer (Stada group) producing a broad Rx and OTC generics portfolio distributed across the Western Balkans — directly comparable to Amsal on product mix, geography and channel strategy.
• Galenika: Serbian generic pharmaceutical manufacturer with a portfolio of Rx and OTC products distributed across the Western Balkans — comparable to Amsal in product category and regional market positioning.
• Farmavita: Bosnian pharmaceutical manufacturer focused on generic Rx and OTC products for the domestic and regional market — directly comparable to Amsal on therapeutic categories and BiH-centric distribution.
• Zada Pharmaceuticals: Bosnian pharmaceutical company producing generic medicines, OTC products and dietary supplements for the BiH market — directly comparable to Amsal on geography, product mix and channel approach.

Broad incumbents

• KRKA: Slovenian-based global generic pharmaceutical manufacturer with a broad Rx, OTC and animal health portfolio; serves the same Western Balkan markets as Amsal but at materially larger scale — a broad incumbent competitor.
• Teva Pharmaceutical Industries: One of the world's largest generic pharmaceutical manufacturers, with broad European distribution including the Western Balkans — competes with Amsal on many of the same off-patent molecules at global scale.
• Sandoz: Global generics and biosimilars manufacturer (Novartis group) with broad Rx generic and OTC presence across Europe — a large-scale incumbent that competes on price in the same off-patent molecules Amsal manufactures.
• STADA Arzneimittel AG: German-headquartered global generics and consumer healthcare company that owns Hemofarm; competes with Amsal across generics, OTC and supplements across Southeastern Europe at significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/amsal.pharmaceuticals
• LinkedInlinkedin.com/company/amsal-pharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amsal Pharmaceuticals Company